Objective: Associations between dysphonia and paradoxical vocal fold motion (PVFM) have been previously reported in adults, but it is unclear whether similar associations exist for adolescents. The goals of this study were to identify the prevalence and severity of voice disorders in adolescent patients with PVFM, identify differences between those with and without clinician-identified dysphonia, and investigate what factors were associated with voice handicap in this population. Methods: A retrospective review of eligible adolescent patients diagnosed with PVFM over a 1-year period at a single institution was undertaken. Data collected from the medical record included demographic background, medical history and workup, patient- and family-reported symptoms, and findings from the laryngeal examination. The presence or absence of clinician-diagnosed dysphonia was used to subdivide the sample for analysis. Results: Forty-eight patients with PVFM were included. The sample was primarily female (73%) with a median age of 15 years. Few patients had voice complaints (5%), but clinician-diagnosed dysphonia was common (52%) and ranged from mild to moderate. Vocal hyperfunction was frequently observed (55%), but anatomic abnormalities associated with dysphonia were rare (6%). Adolescents with dysphonia were significantly older, more likely to have vocal hyperfunction on laryngoscopy, and more likely to return for therapy than those without dysphonia. No notable differences existed in the number of behavioral therapy sessions or in the likelihood of completing treatment between the two groups. The majority of participants (79%) had at least one “confounding factor” (i.e., were currently taking a medication for asthma, allergies, or reflux, or had a laryngeal abnormality) but this did not differ significantly between those with and without dysphonia. A minority of individuals (28%) had abnormal scores on the Voice Handicap Index (VHI). Age was positively correlated with dysphonia severity but no other significant associations were observed. Conclusion: Although voice complaints are rare, dysphonia among adolescents with PVFM is common and can occur in the absence of laryngeal abnormalities and medical comorbidities, typically as a result of vocal hyperfunction. Dysphonia does not appear to be a barrier to PVFM treatment and may be a useful target in therapy.

1.
Tilles
SA
.
Vocal cord dysfunction in children and adolescents
.
Curr Allergy Asthma Rep
.
2003
Nov
;
3
(
6
):
467
72
.
[PubMed]
1529-7322
2.
Patel
RR
,
Venediktov
R
,
Schooling
T
,
Wang
B
.
Evidence-based systematic review: effects of speech-language pathology treatment for individuals with paradoxical vocal fold motion
.
Am J Speech Lang Pathol
.
2015
Aug
;
24
(
3
):
566
84
.
[PubMed]
1058-0360
3.
Vertigan
AE
,
Theodoros
DG
,
Gibson
PG
,
Winkworth
AL
.
The relationship between chronic cough and paradoxical vocal fold movement: a review of the literature
.
J Voice
.
2006
Sep
;
20
(
3
):
466
80
.
[PubMed]
0892-1997
4.
Zelcer
S
,
Henri
C
,
Tewfik
TL
,
Mazer
B
.
Multidimensional voice program analysis (MDVP) and the diagnosis of pediatric vocal cord dysfunction
.
Ann Allergy Asthma Immunol
.
2002
Jun
;
88
(
6
):
601
8
.
[PubMed]
1081-1206
5.
Halvorsen
T
,
Walsted
ES
,
Bucca
C
,
Bush
A
,
Cantarella
G
,
Friedrich
G
, et al
Inducible laryngeal obstruction: an official joint European Respiratory Society and European Laryngological Society statement
.
Eur Respir J
.
2017
Sep
;
50
(
3
):
1602221
.
[PubMed]
0903-1936
6.
Treole
K
,
Trudeau
MD
,
Forrest
LA
.
Endoscopic and stroboscopic description of adults with paradoxical vocal fold dysfunction
.
J Voice
.
1999
Mar
;
13
(
1
):
143
52
.
[PubMed]
0892-1997
7.
Yelken
K
,
Gultekin
E
,
Guven
M
,
Eyibilen
A
,
Aladag
I
.
Impairment of voice quality in paradoxical vocal fold motion dysfunction
.
J Voice
.
2010
Nov
;
24
(
6
):
724
7
.
[PubMed]
0892-1997
8.
Vertigan
AE
,
Theodoros
DG
,
Winkworth
AL
,
Gibson
PG
.
A comparison of two approaches to the treatment of chronic cough: perceptual, acoustic, and electroglottographic outcomes
.
J Voice
.
2008
Sep
;
22
(
5
):
581
9
.
[PubMed]
0892-1997
9.
Powell
DM
,
Karanfilov
BI
,
Beechler
KB
,
Treole
K
,
Trudeau
MD
,
Forrest
LA
.
Paradoxical vocal cord dysfunction in juveniles
.
Arch Otolaryngol Head Neck Surg
.
2000
Jan
;
126
(
1
):
29
34
.
[PubMed]
0886-4470
10.
Murry
T
,
Sapienza
C
.
The role of voice therapy in the management of paradoxical vocal fold motion, chronic cough, and laryngospasm
.
Otolaryngol Clin North Am
.
2010
Feb
;
43
(
1
):
73
83
.
[PubMed]
0030-6665
11.
Vertigan
AE
,
Theodoros
DG
,
Winkworth
AL
,
Gibson
PG
.
Perceptual voice characteristics in chronic cough and paradoxical vocal fold movement
.
Folia Phoniatr Logop
.
2007
;
59
(
5
):
256
67
.
[PubMed]
1021-7762
12.
Mirasola
KL
,
Braun
N
,
Blumin
JH
,
Kerschner
JE
,
Merati
AL
.
Self-reported voice-related quality of life in adolescents with paradoxical vocal fold dysfunction
.
J Voice
.
2008
May
;
22
(
3
):
373
8
.
[PubMed]
0892-1997
13.
Jacobson
BH
,
Johnson
A
,
Grywalski
C
,
Silbergleit
A
,
Jacobson
G
,
Benninger
MS
, et al
The voice handicap index (VHI) development and validation
.
Am J Speech Lang Pathol
.
1997
;
6
(
3
):
66
70
. 1058-0360
14.
Zur
KB
,
Cotton
S
,
Kelchner
L
,
Baker
S
,
Weinrich
B
,
Lee
L
.
Pediatric Voice Handicap Index (pVHI): a new tool for evaluating pediatric dysphonia
.
Int J Pediatr Otorhinolaryngol
.
2007
Jan
;
71
(
1
):
77
82
.
[PubMed]
0165-5876
15.
Zraick
RI
,
Kempster
GB
,
Connor
NP
,
Thibeault
S
,
Klaben
BK
,
Bursac
Z
, et al
Establishing validity of the consensus auditory-perceptual evaluation of voice (CAPE-V)
.
Am J Speech Lang Pathol
.
2011
Feb
;
20
(
1
):
14
22
.
[PubMed]
1058-0360
16.
Drake
K
,
Palmer
AD
,
Schindler
JS
,
Tilles
SA
.
Functional outcomes after behavioral treatment of paradoxical vocal fold motion in adults
.
Folia Phoniatr Logop
.
2017
;
69
(
4
):
154
68
.
[PubMed]
1021-7762
17.
Mathers-Schmidt
BA
,
Brilla
LR
.
Inspiratory muscle training in exercise-induced paradoxical vocal fold motion
.
J Voice
.
2005
Dec
;
19
(
4
):
635
44
.
[PubMed]
0892-1997
18.
Blager
F
:
Vocal cord dysfunction.
Am Speech Lang Hear Assoc SIG 3 Perspect Voice Voice Disord
2006
;16:7–10.
19.
Martin
RJ
,
Blager
FB
,
Gay
ML
,
Wood
RP
 2nd
.
Paradoxical vocal cord motion in presumed asthmatics
.
Semin Respir Med
.
1987
;
8
(
04
):
332
7
.
20.
von Elm
E
,
Altman
DG
,
Egger
M
,
Pocock
SJ
,
Gøtzsche
PC
,
Vandenbroucke
JP
;
STROBE Initiative
.
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
.
J Clin Epidemiol
.
2008
Apr
;
61
(
4
):
344
9
.
[PubMed]
0895-4356
21.
Vassar
M
,
Holzmann
M
.
The retrospective chart review: important methodological considerations
.
J Educ Eval Health Prof
.
2013
Nov
;
10
:
12
.
[PubMed]
1975-5937
22.
Allison
JJ
,
Wall
TC
,
Spettell
CM
,
Calhoun
J
,
Fargason
CA
 Jr
,
Kobylinski
RW
, et al
The art and science of chart review
.
Jt Comm J Qual Improv
.
2000
Mar
;
26
(
3
):
115
36
.
[PubMed]
1070-3241
23.
Landis
JR
,
Koch
GG
.
The measurement of observer agreement for categorical data
.
Biometrics
.
1977
Mar
;
33
(
1
):
159
74
.
[PubMed]
0006-341X
24.
Newman
KB
,
Mason
UG
 3rd
,
Schmaling
KB
.
Clinical features of vocal cord dysfunction
.
Am J Respir Crit Care Med
.
1995
Oct
;
152
(
4 Pt 1
):
1382
6
.
[PubMed]
1073-449X
25.
Patel
NJ
,
Jorgensen
C
,
Kuhn
J
,
Merati
AL
.
Concurrent laryngeal abnormalities in patients with paradoxical vocal fold dysfunction
.
Otolaryngol Head Neck Surg
.
2004
Jun
;
130
(
6
):
686
9
.
[PubMed]
0194-5998
26.
Morrison
M
,
Rammage
L
,
Emami
AJ
.
The irritable larynx syndrome
.
J Voice
.
1999
Sep
;
13
(
3
):
447
55
.
[PubMed]
0892-1997
27.
Sullivan
MD
,
Heywood
BM
,
Beukelman
DR
.
A treatment for vocal cord dysfunction in female athletes: an outcome study
.
Laryngoscope
.
2001
Oct
;
111
(
10
):
1751
5
.
[PubMed]
0023-852X
28.
Blum
H
.
Totally fried
.
ASHA Lead
.
2016
;
21
:
50
6
. 1085-9586
29.
Hartley
NA
,
Petty
BE
,
Johnson
B
,
Thibeault
SL
.
Comparative analysis of clinical profile: chronic cough vs paradoxical vocal fold motion
.
Respir Med
.
2015
Dec
;
109
(
12
):
1516
20
.
[PubMed]
0954-6111
30.
Vertigan
AE
,
Kapela
SM
,
Kearney
EK
,
Gibson
PG
.
Laryngeal dysfunction in cough hypersensitivity syndrome: A cross-sectional observational study
.
J Allergy Clin Immunol Pract
.
2018
Nov - Dec
;
6
(
6
):
2087
95
.
[PubMed]
2213-2198
31.
Pasternak
K
,
Thibeault
SL
.
Factors affecting initiation of voice therapy for paradoxical vocal fold motion disorder
.
J Voice
.
2019
Jan
;
•••
:
S0892-1997(18)30491-0
. ;
Advance online publication
.
[PubMed]
0892-1997
32.
De Bodt
MS
,
Ketelslagers
K
,
Peeters
T
,
Wuyts
FL
,
Mertens
F
,
Pattyn
J
, et al
Evolution of vocal fold nodules from childhood to adolescence
.
J Voice
.
2007
Mar
;
21
(
2
):
151
6
.
[PubMed]
0892-1997
33.
Merati
AL
,
Keppel
K
,
Braun
NM
,
Blumin
JH
,
Kerschner
JE
.
Pediatric Voice-Related Quality of Life: findings in healthy children and in common laryngeal disorders
.
Ann Otol Rhinol Laryngol
.
2008
Apr
;
117
(
4
):
259
62
.
[PubMed]
0003-4894
34.
Karnell
MP
,
Melton
SD
,
Childes
JM
,
Coleman
TC
,
Dailey
SA
,
Hoffman
HT
.
Reliability of clinician-based (GRBAS and CAPE-V) and patient-based (V-RQOL and IPVI) documentation of voice disorders
.
J Voice
.
2007
Sep
;
21
(
5
):
576
90
.
[PubMed]
0892-1997
35.
Gillespie
AI
,
Abbott
KV
.
The influence of clinical terminology on self-efficacy for voice
.
Logoped Phoniatr Vocol
.
2011
Oct
;
36
(
3
):
91
9
.
[PubMed]
1401-5439
36.
Ziegler
A
,
Dastolfo
C
,
Hersan
R
,
Rosen
CA
,
Gartner-Schmidt
J
.
Perceptions of voice therapy from patients diagnosed with primary muscle tension dysphonia and benign mid-membranous vocal fold lesions
.
J Voice
.
2014
Nov
;
28
(
6
):
742
52
.
[PubMed]
0892-1997
37.
Portone
C
,
Johns
MM
 3rd
,
Hapner
ER
.
A review of patient adherence to the recommendation for voice therapy
.
J Voice
.
2008
Mar
;
22
(
2
):
192
6
.
[PubMed]
0892-1997
38.
Abbott
KV
,
Barton
FB
,
Terhorst
L
,
Shembel
A
.
Retrospective studies: A fresh look
.
Am J Speech Lang Pathol
.
2016
May
;
25
(
2
):
157
63
.
[PubMed]
1058-0360
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.